Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization-Reference-Cited by-同舟云学术

Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization

Published:2024-03-13 Issue:6 Volume:8 Page:1379-1383
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Cancilla Daniel¹²,Rettig Michael P.¹^ORCID,Karpova Darja¹^ORCID,Thakellapalli Haresh³^ORCID,Singh Megh¹²,Meyers Marvin J.²³^ORCID,Ruminski Peter G.¹²,Christ Stephanie¹,Chendamarai Ezhilarasi¹,Gao Feng⁴,Gehrs Leah¹,Ritchey Julie K.¹,Prinsen Michael²,DiPersio John F.¹

Affiliation:

1. 1Division of Oncology, Section of Stem Cell Biology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO

2. 2Saint Louis University School of Medicine, St. Louis, MO

3. 3Department of Chemistry, Saint Louis University School of Science and Engineering, St. Louis, MO

4. 4Division of Public Health Sciences, Washington University School of Medicine in St. Louis, St. Louis, MO

Publisher

American Society of Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/8/6/1379/2218959/blooda_adv-2023-011653-main.pdf

Reference21 articles.

1. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years;Passweg;Bone Marrow Transplant,2021

2. The transformative potential of HSC gene therapy as a genetic medicine;Sagoo;Gene Ther,2023